Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease

@article{Palomba2005EfficacyOR,
  title={Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease},
  author={Stefano Palomba and Francesco Orio and Francesco Manguso and Angela I Falbo and Tiziana Russo and Achille Tolino and Libuse Tauchmanov{\`a} and Annamaria Colao and Patrizia Doldo and Pasquale Mastrantonio and Fulvio Zullo},
  journal={Osteoporosis International},
  year={2005},
  volume={16},
  pages={1141-1149}
}
Patients with inflammatory bowel disease (IBD) have frequently a bone mineral density (BMD) significantly lower than age-matched healthy subjects. The low BMD observed in IBD patients is related also to a higher incidence of bone fractures. In this prospective randomized study we evaluated the effect of 1-year risedronate administration on bone mass and turnover, and on vertebral fractures in osteoporotic postmenopausal women with IBD in remission. Ninety osteoporotic postmenopausal women were… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease

  • CJ Dunn, KL Goa
  • J Bone Miner Metab
  • 2004
Highly Influential
5 Excerpts

Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis

  • S Palomba, F JrOrio, +4 authors P Mastrantonio
  • J Clin Endocrinol Metab
  • 2002
Highly Influential
3 Excerpts

Inflammatory bowel disease and the risk of fracture

  • CN Bernstein, JF Blanchard, C Metge, M Yogendran
  • Gastroenterology
  • 2003

Similar Papers

Loading similar papers…